N. Anand et al. / Tetrahedron: Asymmetry 15 (2004) 3131–3138
3137
4.12. Preparation of methyl ( )-anti-3-acetoxy-2-iodo-3-
phenylpropanoate 3c
(1H, d, J = 10.1Hz, CH–Br), 6.08 (1H, d, J =
10.1Hz, CH–OAc), 6.90 (2H, d, J = 8.7Hz, Ar-H),
7.32 (2H, d, J = 8.7Hz, Ar–H). 13C NMR (50MHz): d
14.0, 20.9, 46.7, 53.3, 62.3, 75.3, 113.9, 128.1, 129.3,
160.1, 167.8, 168.8. MS (m/z): 345, 265, 223, 222, 219,
177, 109, 91, 90, 89. Anal. Calcd for C14H17BrO5: C,
48.71; H, 4.96. Found: C, 49.13; H, 5.08.
Compound 3c was prepared from 2c (3.06g, 10.0mmol),
acetic anhydride (1.22g, 12.0mmol) and DMAP (5mg)
following the procedure as described for 3a (3.30g,
95%), mp 57–58ꢁC. IR (KBr): 3006, 2953, 1732, 1436,
1375, 1234, 1130, 1013, 764cmꢂ1
.
1H NMR
(200MHz): d 2.01 (3H, s, –OCOCH3), 3.81 (3H, s,
–COOCH3), 4.65 (1H, d, J = 10.7Hz, CH–I), 6.15 (1H,
d, J = 10.7Hz, CH–OAc), 7.37 (5H, s, Ar–H). 13C
NMR (50MHz): d 20.7, 22.5, 53.1, 77.0, 128.0, 128.5,
129.2, 136.6, 168.7, 169.8. MS (m/z): 348, 273, 263,
220, 204, 198, 182, 167, 166, 151, 150, 140, 124, 108,
96, 80. Anal. Calcd for C12H13IO4: C, 41.40; H, 3.76.
Found: C, 41.03; H, 3.80.
4.16. Preparation of methyl ( )-anti-3-acetoxy-2-iodo-3-
(4-methoxyphenyl)-propanoate 3g
Compound 3g was prepared from 2g (3.36g, 10.0mmol),
acetic anhydride (1.22g, 12.0mmol) and DMAP (5mg)
following the procedure described for 3a (3.40g, 90%),
mp 58ꢁC. IR (neat): 3451, 3005, 2951, 1735, 1611,
1435, 1375, 1022, 958, 830, 777cmꢂ1
.
1H NMR
(200MHz): d 1.99 (3H, s, –OCOCH3), 3.80 (3H, s,
–COOCH3), 3.82 (3H, s, –OCH3), 4.64 (1H, d,
J = 10.8Hz, CH–I), 6.12 (1H, d, J = 10.8Hz, CH–
OAc), 6.90 (2H, d, J = 8.7Hz, Ar–H), 7.33 (2H, d,
J = 8.7Hz, Ar–H). 13C NMR (50MHz): d 20.7, 22.9,
53.1, 55.7, 76.8, 113.8, 128.7, 129.3, 160.1, 168.7,
169.9. MS (m/z): 378, 335, 251, 208, 133, 108. Anal.
Calcd for C13H15IO5: C, 41.30; H, 4.00. Found: C,
41.80; H, 4.04.
4.13. Preparation of ethyl ( )-anti-3-acetoxy-2-iodo-3-
phenylpropanoate 3d
Compound 3d was prepared from 2d (3.19g, 10.0mmol),
acetic anhydride (1.22g, 12.0mmol) and DMAP (5mg)
following the procedure as described for 3a to furnish
3d (3.28g, 91%). IR (neat): 2982, 1738, 1371, 1263,
1
1222, 1017, 967, 699cmꢂ1. H NMR (200MHz): d 1.29
(3H, t, J = 7.1Hz, –COOCH2CH3), 1.98 (3H, s,
–OCOCH3), 4.27 (2H, q, J = 7.1Hz, –COOCH2), 4.62
(1H, d, J = 10.8Hz, CH–I), 6.15 (1H, d, J = 10.8Hz,
CH–OAc), 7.38 (5H, s, Ar–H). 13C NMR (50MHz): d
13.8, 20.6, 23.1, 62.1, 76.7, 128.0, 128.4, 129.1, 136.6,
168.6, 169.2. MS (m/z): 362, 236, 215, 194, 177, 150,
147, 132, 108, 105, 91. Anal. Calcd for C13H15IO4: C,
43.12; H, 4.18. Found: C, 43.23; H, 4.22.
4.17. Preparation of ethyl ( )-anti-3-acetoxy-2-iodo-3-(4-
methoxyphenyl)-propanoate 3h
Compound 3h was prepared from 2h (3.50g, 10.0mmol),
acetic anhydride (1.22g, 12.0mmol) and DMAP (5mg)
following the above procedure (3.56g, 91%), mp 51–
53ꢁC. IR (neat): 2981, 1739, 1612, 1516, 1371, 1252,
1
1224, 1177, 1019, 967, 832cmꢂ1. H NMR (200MHz):
d 1.30 (3H, t, J = 7.1Hz, –COOCH2CH3), 1.98 (3H, s,
–OCOCH3), 3.81 (3H, s, –OCH3), 4.26 (2H, q,
J = 7.1Hz, –COOCH2), 4.61 (1H, d, J = 10.9Hz, CH–
I), 6.12 (1H, d, J = 10.9Hz, CH–OAc), 6.90 (2H, d,
J = 8.7Hz, Ar–H), 7.34 (2H, s, J = 8.7Hz, Ar-H). 13C
NMR (50MHz): d 13.8, 20.7, 23.6, 55.2, 62.0, 76.4,
113.8, 128.7, 129.3, 160.1, 168.7, 169.4. MS (m/z): 392,
347, 333, 262, 222, 213, 206, 189, 179, 137, 132. Anal.
Calcd for C14H17IO5: C, 42.87; H, 4.37. Found: C,
43.33; H, 4.44.
4.14. Preparation of methyl ( )-anti-3-acetoxy-2-bromo-
3-(4-methoxyphenyl)-propanoate 3e
Compound 3e was prepared from 2e (2.89g, 10.0mmol),
acetic anhydride (1.22g, 12.0mmol) and DMAP (5mg)
following the procedure as described for 3a (3.11g,
94%). IR (neat): 3004, 2956, 1748, 1612, 1516, 1371,
1
1022, 964, 832cmꢂ1. H NMR (200MHz): d 2.00 (3H,
s, –OCOCH3), 3.81 (3H, s, COOCH3), 3.82 (3H, s,
–OCH3), 4.71 (1H, d, J = 10.2Hz, CH–Br), 6.10 (1H,
d, J = 10.2Hz, CH–OAc), 6.90 (2H, d, J = 8.7Hz, Ar–
H), 7.32 (2H, d, J = 8.7Hz, Ar–H). 13C NMR
(50MHz): d 20.6, 22.8, 53.3, 62.3, 75.3, 113.9, 128.1,
129.3, 160.1, 167.8, 168.8. MS (m/z): 331, 251, 209,
207, 177, 153, 136, 134. Anal. Calcd for C13H15BrO5:
C, 47.13; H, 4.53. Found: C, 47.41; H, 4.49.
4.18. General procedure of lipase catalyzed kinetic
resolution of 3
In a typical experiment, a mixture of substrate 3a
(800mg, 2.7mmol), toluene (1.6mL), crude powder of
enzyme AS Amano (800mg) in 14.4mL phosphate buf-
fer (pH7.0, 0.1M) was stirred at 30 1ꢁC. The course
of the reaction was monitored by chiral HPLC. After
a certain degree of conversion, the reaction was termi-
nated and contents extracted with ethyl acetate
(3 · 50mL), and organic phase washed with water, dried
over sodium sulfate and concentrated in vacuo to give
the crude product, which after column chromatography
4.15. Preparation of ethyl ( )-anti-3-acetoxy-2-bromo-3-
(4-methoxyphenyl)-propanoate 3f
Compound 3f was prepared from 2f (3.03g, 10.0mmol),
acetic anhydride (1.22g, 12.0mmol) and DMAP (5mg)
following the procedure as described for 3a (3.21g,
93%), mp 54–55ꢁC. IR (neat): 2984, 1746, 1371,
1268, 1221, 1147, 1020, 763, 698, 611, 580, 541cmꢂ1
.
on silica gel with ethyl acetate–hexane (3:97) as
¼
25
D
1H NMR (200MHz): d 1.31 (3H, t, J = 7.1Hz,
–COOCH2CH3), 2.00 (3H, s, –OCOCH3), 3.81 (3H, s,
–OCH3), 4.25 (2H, q, J = 7.1Hz, –COOCH2), 4.69
eluent furnished (ꢂ)-4a (385mg, 42%): ee 94%, ½aꢁ
25
ꢂ19:9 (c 1, CHCl3) and (+)-5a (250mg, 42%): ee 70%,
½aꢁ ¼ þ41:3 (c 1, CHCl3).
D